We are live on ! Find out more
LIMNW

Liminatus Pharma Warrants

26 hedge funds and large institutions have $400K invested in Liminatus Pharma Warrants in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

4% more funds holding

Funds holding: 2526 (+1)

10.2% less ownership

Funds ownership: 44.33%34.12% (-10%)

52% less capital invested

Capital invested by funds: $837K → $400K (-$437K)

86% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 7

Holders
26
Holders Change
+1
Holders Change %
+4%
% of All Funds
0.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
7
Closed
1
Calls
$10K
Puts
Net Calls
+$10K
Net Calls Change
-$7K
Name Holding Trade Value Shares
Change
Change in
Stake
CS
1
Clear Street
New York
$119K -$20 -100 -0%
AC
2
Aristeia Capital
Connecticut
$47.3K +$1.22K +6,272 +2%
LA
3
Linden Advisors
New York
$39.7K
SCM
4
Saba Capital Management
New York
$34.6K
MCM
5
Moore Capital Management
New York
$18.5K
PAMP
6
Polar Asset Management Partners
Ontario, Canada
$18.2K
HCM
7
Highbridge Capital Management
New York
$17.3K
MI
8
MMCAP International
Cayman Islands
$16.5K
Nomura Holdings
9
Nomura Holdings
Japan
$11.7K +$19K +97,325 New
AWG
10
Alpha Wave Global
New York
$10.7K
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$10K
WAM
12
Wolverine Asset Management
Illinois
$9.3K -$7.83K -40,124 -39%
BOCH
13
Blue Owl Capital Holdings
New York
$7.39K
PC
14
Periscope Capital
Ontario, Canada
$7.03K -$488 -2,500 -5%
Toronto Dominion Bank
15
Toronto Dominion Bank
Ontario, Canada
$5.2K -$20 -100 -0.3%
GS
16
GTS Securities
New York
$4.44K +$5.86K +30,000 New
LP
17
LMR Partners
United Kingdom
$4.43K
ACA
18
Arena Capital Advisors
California
$4.32K
Jane Street
19
Jane Street
New York
$3.61K -$491 -2,516 -9%
LIA
20
Limestone Investment Advisors
New York
$3.34K
CSS
21
Cubist Systematic Strategies
Connecticut
$2.33K
MC
22
Meteora Capital
Florida
$2.22K
FTUS
23
Flow Traders U.S.
New York
$2K
DCM
24
Dupont Capital Management
Delaware
$925
HIM
25
HGC Investment Management
Ontario, Canada
$185

LIMNW Hedge Fund Activity: Q3 2025 in Review

26 of the 7,622 institutional investors tracked by Wall St. Rank reported a position in Liminatus Pharma Warrants (LIMNW) for Q3 2025, worth a combined $400K — down 52% from $837K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new LIMNW positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 7 trimmed.

The largest buyer was Nomura Holdings, opening a new position worth an estimated $19K. The largest seller was Cantor Fitzgerald, exiting entirely with an estimated $210K sold.

  • 26 institutional investors held Liminatus Pharma Warrants (LIMNW) as of Q3 2025, up from 25 in Q2 2025.
  • Funds reported $400K of Liminatus Pharma Warrants stock for Q3 2025, down 52% quarter-over-quarter.
  • 2 funds opened new Liminatus Pharma Warrants positions in Q3 2025 and 1 closed out, a net change of +1 holder.
  • The largest Liminatus Pharma Warrants buyer in Q3 2025 was Nomura Holdings, an estimated $19K added.
  • The largest Liminatus Pharma Warrants seller in Q3 2025 was Cantor Fitzgerald, an estimated $210K sold.

Based on aggregated 13F filings for Q3 2025.